IMP
Process View
ovulation cycle
The type of sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "ovulation cycle"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NRP1 | neuropilin 1 | 0.682 | ||
| ESR1 | estrogen receptor 1 | 0.574 | Mouse | |
| BCL2 | B-cell CLL/lymphoma 2 | 0.501 | Mouse Rat | |
| BCL2L1 | BCL2-like 1 | 0.299 | Mouse Rat | |
| POU5F1 | POU class 5 homeobox 1 | 0.236 | ||
| EGFR | epidermal growth factor receptor | 0.222 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.193 | ||
| INSR | insulin receptor | 0.192 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.180 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.178 | ||
| LAT | linker for activation of T cells | 0.154 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.140 | ||
| MPDZ | multiple PDZ domain protein | 0.138 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.124 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.120 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.119 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.110 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.101 | ||
| PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 | 0.090 | ||
| CCND1 | cyclin D1 | 0.087 | ||
| PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | 0.086 | ||
| GAS6 | growth arrest-specific 6 | 0.080 | ||
| FOXO1 | forkhead box O1 | 0.074 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.074 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.072 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.069 | ||
| PGR | progesterone receptor | 0.060 | Mouse Rat | |
| EIF2B4 | eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa | 0.056 | ||
| RNR2 | l-rRNA | 0.055 | ||
| SP1 | Sp1 transcription factor | 0.054 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.052 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.052 | Rat | |
| PGF | placental growth factor | 0.048 | ||
| RB1 | retinoblastoma 1 | 0.048 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.047 | Rat | |
| PPP5C | protein phosphatase 5, catalytic subunit | 0.047 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.046 | ||
| JDP2 | Jun dimerization protein 2 | 0.041 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.041 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.039 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.038 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.036 | ||
| EP300 | E1A binding protein p300 | 0.035 | ||
| TP53 | tumor protein p53 | 0.034 | ||
| CCND3 | cyclin D3 | 0.033 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.032 | ||
| KITLG | KIT ligand | 0.028 | ||
| PSMC5 | proteasome (prosome, macropain) 26S subunit, ATPase, 5 | 0.028 | ||
| A2M | alpha-2-macroglobulin | 0.025 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.025 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.023 | ||
| FST | follistatin | 0.022 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.022 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.022 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.021 | ||
| TDGF1 | teratocarcinoma-derived growth factor 1 | 0.021 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.020 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.020 | ||
| PSMD2 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 | 0.018 | ||
| CUEDC2 | CUE domain containing 2 | 0.018 | ||
| NCOA7 | nuclear receptor coactivator 7 | 0.017 | ||
| IRS1 | insulin receptor substrate 1 | 0.017 | ||
| RNF144B | ring finger protein 144B | 0.017 | ||
| BAD | BCL2-associated agonist of cell death | 0.017 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.017 | ||
| THBS2 | thrombospondin 2 | 0.016 | ||
| NF2 | neurofibromin 2 (merlin) | 0.016 | ||
| SCOC | short coiled-coil protein | 0.015 | ||
| GDF5 | growth differentiation factor 5 | 0.015 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.015 | ||
| KAT2A | K(lysine) acetyltransferase 2A | 0.015 | ||
| EIF2B5 | eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa | 0.014 | ||
| JAK2 | Janus kinase 2 | 0.014 | ||
| CCNA1 | cyclin A1 | 0.014 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.014 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.014 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.014 | ||
| FSTL1 | follistatin-like 1 | 0.014 | ||
| MTA3 | metastasis associated 1 family, member 3 | 0.014 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.014 | ||
| EIF2B2 | eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa | 0.014 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.013 | ||
| LIMK1 | LIM domain kinase 1 | 0.013 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.013 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.012 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.011 | ||
| TBP | TATA box binding protein | 0.011 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.011 | ||
| VEGFC | vascular endothelial growth factor C | 0.011 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.011 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.010 |